Is interventional treatment for liver cancer effective? What are the risks of interventional treatment?

What are the risks of treatment?

Interventional therapy is definitely risky, and any surgery is a double-edged sword. The most common side effect of interventional therapy is nausea and vomiting, which is related to the effects of chemotherapy drugs. The second side effect is fever. The increase in body temperature caused by interventional therapy is mainly related to the need for the body to absorb the necrosis of the tumor. These are relatively common side effects. The most serious side effect is liver failure, which is a relatively low probability of occurrence. If liver failure occurs, it usually occurs in liver cancer with a tumor diameter of more than 10 cm. Therefore, in this case, tumor embolization should be chosen with caution.

Which patients can undergo chemoembolization?

Whether or not hepatic artery chemoembolization can be performed has particularly strict indications. First, liver function must meet the requirements. It is generally recommended that patients with liver function grade C or above can undergo chemoembolization. Patients can consult a doctor whether they meet the standards. The second point is that renal function must meet the requirements. If the renal function is particularly poor, you need to be cautious when choosing contrast agents. Contrast agents are divided into hyperosmolar and hypoosmolar. Since contrast agents need to be metabolized by the kidneys, patients with poor renal function should try to choose hypoosmolar contrast agents that have little effect on the kidneys. The third point is that routine blood tests must meet the requirements. According to the bone marrow suppression score, patients with degrees 2 or above can undergo interventional treatment.